PAHC PEER ANALYSIS

Phibro Animal Health Corporation — metric-by-metric comparison with peers and the industry median

PAHCPhibro Animal Health Corporation

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

PAHCIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	PAHC	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
P/E	14.33●	—	—	46.82	22.08	31.28	21.37
P/B	3.77	-0.88●	0.80	3.47	4.32	1.98	1.82
EV/EBITDA	9.21	4.05●	33.84	14.07	14.64	19.15	12.26
P/S	0.91	0.21●	5.03	1.86	3.93	3.94	2.09

Financial Health
Metric	PAHC	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Current Ratio	3.17	1.32	1.73	1.33	3.66●	0.92	2.22
Debt/Equity	217.6%	-1,010.0%●	5.9%	41.0%	17.0%	52.3%	46.3%
NetDebt/EBITDA	3.15	3.71	-0.10●	1.10	0.09	3.50	1.24

Profitability
Metric	PAHC	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Net Margin	6.3%	-13.5%	-3.6%	4.0%	17.8%●	12.6%	4.0%
ROE	30.3%●	—	-0.6%	8.7%	20.9%	6.3%	6.4%
ROA	6.9%	-4.7%	-0.5%	4.8%	15.1%●	3.2%	3.4%
EBITDA Margin	15.0%	60.0%●	14.8%	14.3%	27.0%	25.2%	18.2%

Growth + Dividend
Metric	PAHC	BHC	ECILC	GENIL	ROVI	HLN	Ind. Median
Rev. Growth	26.0%●	-9.9%	-2.3%	16.3%	-3.4%	-26.7%	7.5%
NI Growth	199.6%●	—	—	146.6%	-5.9%	-14.2%	5.0%
Div. Yield	1.5%	0.0%	2.6%●	0.0%	1.6%	2.0%	2.0%
Payout	20.4%	0.0%	-365.1%	0.0%	36.3%	40.0%	0.8%

Valuation
Metric	PAHC	XERS	COLL	PRGO	HROW	PCRX	Ind. Median
P/E	14.33●	122.48	19.80	—	—	202.16	21.37
P/B	3.77	113.04	4.75	0.61●	55.43	1.59	1.82
EV/EBITDA	9.21	30.27	3.07●	—	57.12	10.54	12.26
P/S	0.91	4.67	1.86	0.37●	5.92	1.41	2.09

Financial Health
Metric	PAHC	XERS	COLL	PRGO	HROW	PCRX	Ind. Median
Current Ratio	3.17	2.12	1.71	2.72	2.48	4.73●	2.22
Debt/Equity	217.6%	286.9%	258.6%	152.3%	1,047.4%	62.9%●	46.3%
NetDebt/EBITDA	3.15	-1.61	0.63	-2.78●	6.55	1.77	1.24

Profitability
Metric	PAHC	XERS	COLL	PRGO	HROW	PCRX	Ind. Median
Net Margin	6.3%	3.8%	9.4%●	-43.5%	-5.6%	0.7%	4.0%
ROE	30.3%●	—	27.4%	-53.0%	-35.1%	0.7%	6.4%
ROA	6.9%●	3.4%	4.6%	-20.5%	-3.8%	0.4%	3.4%
EBITDA Margin	15.0%	14.7%	76.6%●	-29.7%	11.7%	16.1%	18.2%

Growth + Dividend
Metric	PAHC	XERS	COLL	PRGO	HROW	PCRX	Ind. Median
Rev. Growth	26.0%	41.5%●	19.9%	-3.6%	26.2%	4.6%	7.5%
NI Growth	199.6%●	—	70.7%	—	—	—	5.0%
Div. Yield	1.5%	—	—	11.3%●	—	—	2.0%
Payout	20.4%	—	—	-8.7%	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PAHC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.